Reference health
Relationship between International Normalized Ratio and Outcomes in Modern Trials with Warfarin Controls
34/34 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 34 checked references that resolve
resolves10.1001/archinte.1994.00420130036007
Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
resolves10.7326/0003-4819-146-12-200706190-00007
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
resolves10.1161/CIR.0000000000000041
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
resolves10.1055/s-0038-1651587
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
resolves10.1056/NEJM199309023291001
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
resolves10.1056/NEJM199608223350802
An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation
resolves10.1016/j.thromres.2004.11.025
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
resolves10.1056/NEJM199511303332213
Optimal Oral Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral Ischemia
resolves10.1016/S0140-6736(96)03487-3
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
resolves10.1111/j.1532-5415.2006.00828.x
Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study
resolves10.1056/NEJMoa022913
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
resolves10.1503/cmaj.080171
Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis
resolves10.1161/CIR.0b013e318214876d
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
resolves10.1161/01.STR.31.4.817
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
resolves10.1111/j.1365-2125.2005.02361.x
Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate‐intensity anticoagulation?
resolves10.7326/0003-4819-141-10-200411160-00005
Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation
resolves10.7326/0003-4819-120-11-199406010-00001
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
resolves10.1161/01.CIR.0000145172.55640.93
Selecting Patients With Atrial Fibrillation for Anticoagulation
resolves10.1016/S0735-1097(99)00489-1
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
resolves10.1378/chest.09-1584
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
resolves10.1016/j.thromres.2011.07.004
Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation
The 2 references without a DOI — listed, not checked
no DOI — not checkedOral anticoagulants for preventing stroke in patients with non‐valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
no DOI — not checkedEuropean Medicines Agency.Assessment report: Xarelto.2016. Available fromhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500201726.pdf. Accessed June 20 2016.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/phar.2161"><img src="https://citestamp.com/citestamped/10.1002/phar.2161/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/phar.2161)